4.5 Article

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection

Related references

Note: Only part of the references are listed.
Review Immunology

New Japanese encephalitis vaccines: alternatives to production in mouse brain

Scott B. Halstead et al.

EXPERT REVIEW OF VACCINES (2011)

Article Immunology

CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria

Arturo Reyes-Sandoval et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Immunology

Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults

Clayton D. Harro et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)

Review Immunology

T-cell quality in memory and protection: implications for vaccine design

Robert A. Seder et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Multidisciplinary Sciences

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

DP Webster et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

RB Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)